2025
Fauvel C et al. In-hospital and 1 year incremental prognostic value of drug abuse detection in acute heart failure. ESC Heart Fail. 2025 May 21. doi: 10.1002/ehf2.15118. Epub ahead of print. PMID: 40396434.
Mirabel M, et al. Increased cancer incidence in patients with pre-existing heart failure: results from a French nationwide cohort study. Eur J Prev Cardiol. 2025 Mar 20:zwaf152. doi: 10.1093/eurjpc/zwaf152. PMID: 40111173.
Hermida A, et al. Systematic analysis of SCN5A variants associated with inherited cardiac diseases. Heart Rhythm. 2025 Mar;22(3):844-851. doi: 10.1016/j.hrthm.2024.08.018. Epub 2024 Aug 10. PMID: 39134129.
Sibilia B, et al. Supervised machine learning including environmental factors to predict in-hospital outcomes in acute heart failure patients, European Heart Journal - Digital Health, Volume 6, Issue 2, March 2025, Pages 190–199. doi:10.1093/ehjdh/ztae094
2024
Hagège A, et al. The French hypertrophic cardiomyopathy gene register: A systematic large gene screening for hypertrophic cardiomyopathy. Int J Cardiol. 2024 Dec 15;417:132542. doi: 10.1016/j.ijcard.2024.132542. Epub 2024 Sep 10. Erratum in: Int J Cardiol. 2025 Jan 15;419:132692. doi: 10.1016/j.ijcard.2024.132692. PMID: 39260623.
Nicol M, et al. Prognostic value of CMR-derived extracellular volume in AL amyloidosis: a multicenter study. Amyloid. 2024 Dec;31(4):318-325. doi: 10.1080/13506129.2024.2406842. Epub 2024 Sep 25. PMID: 39319571.
de Freminville JB, et al. Prevalence and Risk Factors for Secondary Hypertension in Young Adults. Hypertension. 2024 Nov;81(11):2340-2349. doi: 10.1161/HYPERTENSIONAHA.124.22753. Epub 2024 Sep 19. PMID: 39297209.
Ed Demri Y, et al. Prediction of Positive Genetic Testing for Arrhythmogenic Left Ventricular Cardiomyopathy. Circ Genom Precis Med. 2024 Aug;17(4):e004612. doi: 10.1161/CIRCGEN.124.004612. Epub 2024 Jul 29. PMID: 39069921.
Domengé O, et al. Heart failure associated with socioeconomic status stronger in younger patients: a French nationwide cohort study. Eur J Prev Cardiol. 2024 Aug 22;31(11):1427-1429. doi: 10.1093/eurjpc/zwae083. PMID: 38441417.
Mirabel M, et al. Adverse myocardial and vascular side effects of immune checkpoint inhibitors: a prospective multimodal cardiovascular assessment. Clin Res Cardiol. 2024 Aug;113(8):1263-1273. doi: 10.1007/s00392-024-02462-x. Epub 2024 May 28. PMID: 38806821.
Parodi A, et al. Target population for a selective cardiac myosin inhibitor in hypertrophic obstructive cardiomyopathy: Real-life estimation from the French register of hypertrophic cardiomyopathy (REMY). Arch Cardiovasc Dis. 2024 Jun-Jul;117(6-7):427-432. doi: 10.1016/j.acvd.2024.04.001. Epub 2024 May 7. PMID: 38762345.
Carette C, et al. Systematic Brain Natriuretic Peptide Measurement for Cardiac Screening in Patients with Severe Obesity: The OLECOEUR Study. Obes Facts. 2024;17(3):296-302. doi: 10.1159/000538766. Epub 2024 Apr 6. PMID: 38583425; PMCID: PMC11149975.
Domengé O, et al. - Trends in prevalence of major etiologies leading to heart failure in young patients: An integrative review. Trends Cardiovasc Med. 2024 Feb;34(2):80-88. doi: 10.1016/j.tcm.2022.09.005. Epub 2022 Sep 22. PMID: 36155830.
2023
Zhang Y, et al. Genetic inhibition of CARD9 accelerates the development of atherosclerosis in mice through CD36 dependent-defective autophagy. Nat Commun. 2023 Aug 1;14(1):4622. doi: 10.1038/s41467-023-40216-x. PMID: 37528097; PMCID: PMC10394049.
Bruno RM, et al. Sex and Gender VascAgeNet Expert Group. Vascular function in hypertension: does gender dimension matter? J Hum Hypertens. 2023 Aug;37(8):634-643. doi: 10.1038/s41371-023-00826-w. Epub 2023 Apr 15. PMID: 37061653.
Azizi M, et al. Endovascular Ultrasound Renal Denervation to Treat Hypertension. The RADIANCE II Randomized Clinical Trial. JAMA. 2023 Feb 28; 329(8):651-661. doi:10.1001/jama.2023.0713
Lecoeur E, et al. Epidemiology of heart failure in young adults: a French nationwide cohort study. Eur Heart J. 2023 Feb 1;44(5):383-392. doi: 10.1093/eurheartj/ehac651. Erratum in: Eur Heart J. 2024 Jul 9;45(26):2335. doi: 10.1093/eurheartj/ehae187. PMID: 36452998; PMCID: PMC9890267.
Yoganathan T, et al. Acute stress induces long-term metabolic, functional, and structural remodeling of the heart. Nat Commun. 2023 Jun 28;14(1):3835. doi: 10.1038/s41467-023-39590-3. Erratum in: Nat Commun. 2023 Jul 12;14(1):4143. doi: 10.1038/s41467-023-39910-7. PMID: 37380648; PMCID: PMC10307856.
Arisido MW, et al. Cluster analysis of angiotensin biomarkers to identify antihypertensive drug treatment in population studies. BMC Med Res Methodol. 2023 May 27;23(1):131. doi: 10.1186/s12874-023-01930-8. PMID: 37245005; PMCID: PMC10224304.
Masurkar N, et al. Novel Cardiokine GDF3 Predicts Adverse Fibrotic Remodeling After Myocardial Infarction. Circulation. 2023 Feb 7;147(6):498-511. doi: 10.1161/CIRCULATIONAHA.121.056272.
Liu L, et al. Genomic, Transcriptomic, and Proteomic Depiction of Induced Pluripotent Stem Cells-Derived Smooth Muscle Cells As Emerging Cellular Models for Arterial Diseases. Hypertension. 2023 Apr;80(4):740-753. doi: 10.1161/HYPERTENSIONAHA.122.19733. Epub 2023 Jan 19. PMID: 36655574.
2022
Lopes LR, et al. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry. Eur Heart J Qual Care Clin Outcomes. 2022 Dec 13;9(1):42-53. doi: 10.1093/ehjqcco/qcac006. PMID: 35138368; PMCID: PMC9745665.
Azizi M, et al. Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation. JAMA Cardiology. 2022 Nov 9; 7(12):1244-1252. doi: 10.1001/jamacardio.2022.3904
Peronino C, et al. Bioprosthetic Total Artificial Heart Implantation Does Not Induce Chronic Inflammation. ASAIO J. 2022 Nov 1;68(11):e173-e178. doi: 10.1097/MAT.0000000000001820. Epub 2022 Oct 12. PMID: 36228635.
Jouve C, et al - Cardiomyocytes derived from human-induced pluripotent stem cell culture in rod-shaped micropattern. Arch Cardiovasc Supp. 2022 Jun; 14 (2):180-181 . doi : 10.1016/j.acvdsp.2022.04.057
Khairy P, et al. Sudden cardiac death in congenital heart disease. Eur Heart J. 2022 Jun 6;43(22):2103-2115. doi: 10.1093/eurheartj/ehac104. PMID: 35302168.
Delacroix C, et al - Rôle des intégrines dans la fibrose cardiaque. Med Sci (Paris), 2022 May; 38 : 438-444. doi : 10.1051/medsci/2022055
Kandzari DE, et al. Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium. Circulation. 2022 Mar 15;145(11):847-863. doi: 10.1161/CIRCULATIONAHA.121.057687. Epub 2022 Mar 14. PMID: 35286164; PMCID: PMC8912966.
Sun Y, et al. Splenic Marginal Zone B Lymphocytes Regulate Cardiac Remodeling After Acute Myocardial Infarction in Mice. J Am Coll Cardiol. 2022 Feb 22;79(7):632-647. doi: 10.1016/j.jacc.2021.11.051. PMID: 35177192.
2021
Ladouceur M, et al. Effect of medical treatment on heart failure incidence in patients with a systemic right ventricle. Heart. 2021 Sep;107(17):1384-1389. doi: 10.1136/heartjnl-2020-318787. Epub 2021 May 6. PMID: 33958396.
Betton M, et al. Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019. Clin Infect Dis. 2021 Sep 15;73(6):e1337-e1344. doi: 10.1093/cid/ciab308. PMID: 33851216; PMCID: PMC8083257.
Waldmann V, et al - Catheter ablation in adults with congenital heart disease: A 15-year perspective from a tertiary centre. Arch Cardiovasc Dis. 2021 Jun-Jul;114(6-7):455-464. doi: 10.1016/j.acvd.2020.12.005. Epub 2021 Apr 10. PMID: 33846095.
Baron É, et al. - Management and outcomes of hypertrophic cardiomyopathy in young adults. Arch Cardiovasc Dis. 2021 Jun-Jul;114(6-7):465-473. doi: 10.1016/j.acvd.2020.12.006. Epub 2021 Mar 17. PMID: 33744178.
Fayol A, et al. - French COVID cohort study group. Cardiac performance in patients hospitalized with COVID-19: a 6 month follow-up study. ESC Heart Fail. 2021 Jun;8(3):2232-2239. doi: 10.1002/ehf2.13315. Epub 2021 Mar 27. PMID: 33773099; PMCID: PMC8120370.
Azizi M, et al. - Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial. Lancet. 2021 Jun 26;397(10293):2476-2486. doi: 10.1016/S0140-6736(21)00788-1. Epub 2021 May 16. PMID: 34010611.
Seguret M, et al. - Cardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies. Biomedicines. 2021 May 18;9(5):563. doi: 10.3390/biomedicines9050563. PMID: 34069816; PMCID: PMC8157277.
Jouve C, et al - Improvement in mitochondrial oxidative phosphorylation of cardiomyocytes derived from human-induced pluripotent stem cells using micropatterned anisotropic substrates. Arch Cardiovasc Dis. 2021 May; 13 (2), 207-208. doi: 10.1016/j.acvdsp.2021.04.146
Garnier S, et al - Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23. Eur Heart J. 2021 May 21;42(20):2000-2011. doi: 10.1093/eurheartj/ehab030. Erratum in: Eur Heart J. 2021 May 21;42(20):2011. doi: 10.1093/eurheartj/ehab192. PMID: 33677556; PMCID: PMC8139853.
Santos-Zas I, et al. - Cytotoxic CD8+ T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling. Nat Commun. 2021 Mar 5;12(1):1483. doi: 10.1038/s41467-021-21737-9. PMID: 33674611; PMCID: PMC7935973.
Hulot JS, et al. - HFpEF: Should We Consider Diabetic Patients Separately?: The Cardiomyocytes Say Yes. - J Am Coll Cardiol. 2021 Feb 2;77(4):420-422. doi: 10.1016/j.jacc.2020.11.051. PMID: 33509398.
Melhem NJ, et al. - Endothelial Cell Indoleamine 2, 3-Dioxygenase 1 Alters Cardiac Function After Myocardial Infarction Through Kynurenine. Circulation. 2021 Feb 9;143(6):566-580. doi: 10.1161/CIRCULATIONAHA.120.050301. Epub 2020 Dec 4. PMID: 33272024.
2019
Georges A, et al. La génétique établit le lien entre plusieurs maladies cardiovasculaires affectant préférentiellement les femmes. Med. Sci. (Paris), 35 8-9 (2019) 605-607. doi:10.1051/medsci/2019119
Madonna, R, et al. ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure, Cardiovascular Research, Volume 115, Issue 3, 1 March 2019, Pages 488–500. doi: 10.1093/cvr/cvz010